Tuesday, May 07, 2019 10:12:27 AM
Complete scam!
Their filings confirm it's a scam!
Anyone remember what the share price for this scam was before the disastrous RS?? Yea, the move that would allow this scam to up list, and complete the S1 funding scam......?
No legitimate business of bank will touch this. There is nothing to invest in. Their supposed cancer drug doesn't exist, they use the narrative to scam people, 9yrs, zero progress. They will never progress it. They are currently drop selling someone elses amino tabs on amazon, lol. I'm sure that's lucrative!! Hahaha.
Toxic debt everywhere, to include debt owed to the CEO. Which equals SCAM!! he charges his company late fees and interest on that debt. Hahaah.....who do you think pays for that?? Shareholders. This is a scam. SBFM IS A BANK FOR A FEW SCAM ARTISTS.
ALL IMO.
Their filings confirm it's a scam!
Anyone remember what the share price for this scam was before the disastrous RS?? Yea, the move that would allow this scam to up list, and complete the S1 funding scam......?
No legitimate business of bank will touch this. There is nothing to invest in. Their supposed cancer drug doesn't exist, they use the narrative to scam people, 9yrs, zero progress. They will never progress it. They are currently drop selling someone elses amino tabs on amazon, lol. I'm sure that's lucrative!! Hahaha.
Toxic debt everywhere, to include debt owed to the CEO. Which equals SCAM!! he charges his company late fees and interest on that debt. Hahaah.....who do you think pays for that?? Shareholders. This is a scam. SBFM IS A BANK FOR A FEW SCAM ARTISTS.
ALL IMO.
Recent SBFM News
- Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin • ACCESS Newswire • 05/21/2026 11:00:00 AM
- Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering • ACCESS Newswire • 05/19/2026 04:05:00 PM
- Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering • ACCESS Newswire • 05/18/2026 04:15:00 PM
- Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year • ACCESS Newswire • 04/06/2026 12:30:00 PM
- Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea • ACCESS Newswire • 10/28/2025 11:45:00 AM
- Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline • ACCESS Newswire • 10/20/2025 11:45:00 AM
- Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin • ACCESS Newswire • 10/16/2025 11:45:00 AM
- Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience • ACCESS Newswire • 10/14/2025 11:00:00 AM
- Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections • ACCESS Newswire • 10/09/2025 12:00:00 PM
